In particular, plasma ET-1 levels are elevated in obese individuals, and this upregulation is associated with increased adipose tissue inflammation, insulin resistance, diabetes mellitus, cardiovascular complications, and hypertension 27, 29, 32-35. Here, EDN1 is linked to hypertensive disorder.